TY - JOUR
T1 - Opportunistic infections in AIDS patients
T2 - Current management and prevention
AU - Hughes, W. T.
PY - 1994/1/1
Y1 - 1994/1/1
N2 - The number of drugs available for treatment and prevention of opportunistic infections in patients who are seropositive for HIV infection is limited, although some agents currently being studied show promise. Pneumocystis carinii pneumonia, the most common opportunistic infection, can be effectively managed, although prophylaxis must be continued indefinitely. Because an increased incidence of tuberculosis is associated with HIV infection, the emergence of strains that are resistant to multiple drugs is of concern. Intensive therapy with five or six drugs may be necessary. Isoniazid (Nydrazid) is recommended for prophylaxis.
AB - The number of drugs available for treatment and prevention of opportunistic infections in patients who are seropositive for HIV infection is limited, although some agents currently being studied show promise. Pneumocystis carinii pneumonia, the most common opportunistic infection, can be effectively managed, although prophylaxis must be continued indefinitely. Because an increased incidence of tuberculosis is associated with HIV infection, the emergence of strains that are resistant to multiple drugs is of concern. Intensive therapy with five or six drugs may be necessary. Isoniazid (Nydrazid) is recommended for prophylaxis.
UR - http://www.scopus.com/inward/record.url?scp=0028040027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028040027&partnerID=8YFLogxK
U2 - 10.1080/00325481.1994.11945782
DO - 10.1080/00325481.1994.11945782
M3 - Article
C2 - 8278302
AN - SCOPUS:0028040027
SN - 0032-5481
VL - 95
SP - 81
EP - 93
JO - Postgraduate Medicine
JF - Postgraduate Medicine
IS - 1
ER -